Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 2
2013 2
2014 3
2015 2
2016 4
2017 9
2018 4
2019 4
2020 4
2021 4
2022 2
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Results by year

Filters applied: . Clear all
Page 1
Theranostics in nuclear medicine practice.
Yordanova A, Eppard E, Kürpig S, Bundschuh RA, Schönberger S, Gonzalez-Carmona M, Feldmann G, Ahmadzadehfar H, Essler M. Yordanova A, et al. Among authors: eppard e. Onco Targets Ther. 2017 Oct 3;10:4821-4828. doi: 10.2147/OTT.S140671. eCollection 2017. Onco Targets Ther. 2017. PMID: 29042793 Free PMC article. Review.
An Impressive Approach in Nuclear Medicine: Theranostics.
Vahidfar N, Eppard E, Farzanehfar S, Yordanova A, Fallahpoor M, Ahmadzadehfar H. Vahidfar N, et al. Among authors: eppard e. PET Clin. 2021 Jul;16(3):327-340. doi: 10.1016/j.cpet.2021.03.011. PET Clin. 2021. PMID: 34053577 Review.
Recent Trends in Diagnostic Biomarkers of Tumor Microenvironment.
Siminzar P, Tohidkia MR, Eppard E, Vahidfar N, Tarighatnia A, Aghanejad A. Siminzar P, et al. Among authors: eppard e. Mol Imaging Biol. 2023 Jun;25(3):464-482. doi: 10.1007/s11307-022-01795-1. Epub 2022 Dec 14. Mol Imaging Biol. 2023. PMID: 36517729 Review.
Theranostic Advances in Breast Cancer in Nuclear Medicine.
Vahidfar N, Aghanejad A, Ahmadzadehfar H, Farzanehfar S, Eppard E. Vahidfar N, et al. Among authors: eppard e. Int J Mol Sci. 2021 Apr 27;22(9):4597. doi: 10.3390/ijms22094597. Int J Mol Sci. 2021. PMID: 33925632 Free PMC article. Review.
Optimal Indications of Radioimmunotherapy in Nuclear Medicine: A Mini-Review.
Vahidfar N, Ahmadzadehfar H, Farzanefar S, Abbasi M, Salehi Y, Saboktakin F, Jahanbin M, Bakhshi Kashi M, Eppard E, Jürgen Biersack H. Vahidfar N, et al. Among authors: eppard e. Curr Radiopharm. 2024 Mar 19. doi: 10.2174/0118744710295825240308093429. Online ahead of print. Curr Radiopharm. 2024. PMID: 38504563
Evaluation of Safety and Dosimetry of 177Lu-DOTA-ZOL for Therapy of Bone Metastases.
Fernández R, Eppard E, Lehnert W, Jiménez-Franco LD, Soza-Ried C, Ceballos M, Ribbeck J, Kluge A, Rösch F, Meckel M, Zhernosekov K, Kramer V, Amaral H. Fernández R, et al. Among authors: eppard e. J Nucl Med. 2021 Aug 1;62(8):1126-1132. doi: 10.2967/jnumed.120.255851. Epub 2021 Jan 8. J Nucl Med. 2021. PMID: 33419945 Free PMC article.
39 results